Transjugular intrahepatic portosystemic shunt (TIPS) is increasingly used worldwide to treat
the complications of portal hypertension in patients with advanced cirrhosis. However, its …

Patients with decompensated cirrhosis are currently managed through targeted strategies
aimed at preventing or treating specific complications. In contrast, a disease-modifying agent …

The Billroth IV consensus was developed during a consensus meeting of the Austrian
Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of …

Background & Aims Nonselective beta blockers (NSBBs) exert beneficial effects beyond
lowering hepatic venous pressure gradient (HVPG), which may be particularly relevant in …

Background In this systematic review and meta-analysis, we examined the evidence on
transjugular intrahepatic portosystemic shunt (TIPS) as a bridge to elective and emergency …

Portal hypertension (PH), a common complication of liver cirrhosis, results in development of
esophageal varices. When esophageal varices rupture, they cause significant upper …

Background & Aims Hepatic encephalopathy (HE) is a frequent and severe complication in
patients after transjugular intrahepatic portosystemic shunt (TIPS) insertion. However, risk …

Portal hypertension is a major complication of cirrhosis characterized by a pathological
hepatic venous pressure gradient (HVPG)≥ 5 mmHg. The structural changes observed in …

(1) Background: Patients with advanced chronic liver disease (ACLD) are living longer with
more comorbidities because of improved medical and surgical management. However …

Ascites represents a critical event in the natural history of liver cirrhosis. From a prognostic
perspective, its occurrence marks the transition from the compensated to the …